Somatostatin

Short description:


  • Product Name:Somatostatin
  • CAS non:38916-34-6
  • Molecular formula:C76h104n18o19s2
  • Molecular pondus:1637.90g / mol
  • Sequence:H-Ala-Gly-CYS, Lys-ASN-Phe-Phe-TRP-Lys-Thre-Phe-Thre-Ser-Cys-O Acetate sal (Disulfide Bond)
  • Species:alba pulveris
  • Application:Ulceris sanguinem, Hemorrhagic GASTRITIS, postoperative pancreaticum et duodenal fistulae, Varicesal Hemorrhage
  • Package:Secundum mos est scriptor requisitis
  • Product Detail

    Product Tags

    Keywords

    • SomatostatinACETATE
    • maxime parabilis pretium
    • CAS # 38916-34-6

    Details

    • Proname:Somatostatin
    • Casno: 38916-34-6
    • Molecular formula: c76h104n18o19s2
    • Specie Alba pulveris
    • Application: Ulcerus Bleeding.hemorrhagic Gastritis.p ...
    • Delivivivivivivivitudine: Promptus Shipment
    • Package: secundum opus tuum
    • Portus: Shenzhen
    • ProductCapacity: II Kilogram / mensis
    • Puritas: XCVIII%
    • PRAECLUSIO: II ~ VIII ℃, protected a lux
    • Translationem: a aere
    • Limitnum: I Gram

    Excellentia

    Professional peptide manufacturer in Sina.
    Qualitas in GMP gradu
    Magna cum competitive pretium
    Nostrum products includit: Generic Bulla peptide Apis, COLOR peptide, Custom Peptides et VETERINARIUS Peptides.

     

    Details

    Molecular formula:

    C76h104n18o19s2

    Missam relativum Missam:

    1637,90 g / mol

    CAS, Number:

    38916-34-6 (rete)

    Long-term repono:

    -20 ± V ° C

    Synonyma:

    Somatostin-XIV; Srif-XIV;
    Somatotropin release-inhibendo factor; Srif

    Sequence:

    H-Ala-Gly-CYS, Lys-ASN-Phe-Phe-TRP-Lys-Thre-Phe-Thre-Ser-Cys-O Acetate sal (Disulfide Bond)

    Agri application:

    Ulceris sanguinem
    Hemorrhagic GASTRITIS
    Postoperative pancreaticum et Duodenal Fistulae
    Varicesal Hemorrhage

    Active substantia:

    Somatostatin (Srif) est inhibitor ex incrementum hormone release ab anterioris pituitam et inde est Anagonist Grof.somatostostin suppresit in release of a varietate alia hormones involved in Tractus. Somatostatin etiam inhibits TSH production.somatostatin est XIV-amino acidum peptide nomine pro sua facultatem ad inhibere pituitam incrementum hormone release, etiam dicitur Somatotropin release-inhibendo factor. Est expressit in centralis et periphericis nervosi systems, in ventrem et aliis organis. SRIF potest etiam inhibere remissionis thyroid-stimulating hormone; Prolactin; Insulin; et glucagon praeter agens neurotransmitter et neuromodulator. In multis speciei inter homines, ibi est additional forma somatostatin, Srif-XXVIII cum a XIV-amino acidum extensio ad N-terminatio.

     

    Company Profile:

     

    Company Name: Shenzhen JMMed Technology Co., Ltd.
    Statutum Year: MMIX
    Capital: 89.5 decies RMB
    Main Product: Oxytocin Acetate, Vasopressin Acetate, Desminin Acetate, Terlipressin Acetate, Caspofungin Acetate, Micafungin Sodium, EPtifibatide Acetate, Bivalin, Liraglutide Acetate, Linaclotide aceteate, degarelix acetate, buserelin acetate, cetrorelix acetate, Goselin
    Acetate, Argirelentia Acetate, Metrixyl Acetate, frangeretur-VIII, .. ...
    Nobis contendunt continuanding innovations in novam peptide synthesis technology et processus optimization et nostra technica quadrigis habere super decennium ex experientia in peptide synthesis.jym has feliciter summitto multum
    De Anda peptide apis et formulavit products cum CFDA et plus quam quadraginta patents probatus.
    Nostra peptide plant sita est in Nanjing, Jiangsu provinciae et posuit eum a facility of 30,000 quadratum metris in obsequio cum CGMP Guideline. Facultatem facilitatem est audited et inspici ab utroque domesticis et internationalis clients.
    Et sua optimum qualis, summa competitive pretium et fortis technica firmamentum, Jym non solum habet lucrata recognitiones pro sua products ex investigationis organizations et pharmaceutical industries, sed etiam facti sunt unus ex fidelissimis amet in Sinis,. Jym dicata est unum de mundo ducens peptide provisor in proximo futurum.

  • Previous:
  • Next:

  • Scribere nuntium hic mitte nobis
    TOP